The global conjugate vaccine market is anticipated to grow significantly at a CAGR of 10.2% during the forecast period (2022-2028). Globally the incidence of infectious diseases continue to have major health and economic costs. Infectious diseases such as Diphtheria, Influenza, Pneumococcal can catch people into poverty and can have devastating effect on the country’s economy. […]
Category Archives: Pharmaceuticals
US prostate cancer market diagnostics and therapeutics are forecast to augment at a CAGR of 10.4% during the forecast period. The major factors for the growth of the market include the high prevalence of prostate cancer in the country. As per the World Health Organization, in US prostate cancer is the most prevalent cancer among […]
UK prostate cancer market is forecast to grow at a CAGR of 9.7% during the forecast period. The high incidence of prostate cancer is the major factor for augmenting the demand for prostate cancer diagnostics services and therapeutics in the country. As per the World Health Organization, around 56,000 new cases of prostate cancer were […]
North American prostate cancer diagnostics and therapeutics market is expected to grow at a CAGR of 10.4% during the forecast period. The major factors for the growth of the market include the high prevalence of prostate cancer in the region which raises the demand for efficient diagnostics and therapies for the treatment of cancer. As […]
India prostate cancer market is forecast to grow at a CAGR of around 9% during the forecast period. The incidence of prostate cancer is less as compared to the western economies as prostate cancer is among the top 3 cancer in men in western economies whereas it is at 16th rank in the incidence cancer […]
Germany prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The high prevalence of prostate cancer in the country is one of the major factors for the demand for prostate cancer diagnostics services and therapeutics. As per the World Health Organization, around 63,000 new cases of prostate cancer […]
France prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The country is among the most susceptible to the prostate cancer in Europe. As per the World Health Organization, around 25% of the overall cancer cases are of prostate cancer, which is around 65,000 in 2018. The 5-year […]
China is the most populated country and an emerging economy. China prostate cancer market is forecast to grow at a CAGR of around 8.5% during the forecast period. The incidence of prostate cancer is less in the country as compared to western economies. As per the World Health Organization, the estimated new cases of prostate […]
Asia Pacific prostate cancer market is expected to grow at a CAGR of 7.9% during the forecast period. As per the World Health Organization, Asia Pacific is the second largest region in terms of new cases of prostate cancer globally. In 2018, around 321,000 new cases of prostate cancer were registered in the region. China […]
The LAMEA indapamide market is estimated to grow significantly during the forecast period. The factors contributing to the growth of the indapamide market include rising cases of diabetes and hypertension among the population. According to the International Diabetes Federation (IDF), Brazil and Mexico are the two countries with a higher number of diabetes cases registered […]